Fibroblast Growth Factor 21 Exerts its Anti-inflammatory Effects on Multiple Cell Types of Adipose Tissue in Obesity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast Growth Factor 21 Exerts its Anti-inflammatory Effects on Multiple Cell Types of Adipose Tissue in Obesity
Authors
Keywords
-
Journal
Obesity
Volume 27, Issue 3, Pages 399-408
Publisher
Wiley
Online
2019-02-01
DOI
10.1002/oby.22376
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improving hyperglycemic effect of FGF-21 is associated with alleviating inflammatory state in diabetes
- (2018) Nan Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Obesity as a Disease
- (2018) Jagriti Upadhyay et al. MEDICAL CLINICS OF NORTH AMERICA
- Inflammatory mechanisms linking obesity and metabolic disease
- (2017) Alan R. Saltiel et al. JOURNAL OF CLINICAL INVESTIGATION
- Adapting to obesity with adipose tissue inflammation
- (2017) Shannon M. Reilly et al. Nature Reviews Endocrinology
- Resveratrol mitigates lipopolysaccharide-mediated acute inflammation in rats by inhibiting the TLR4/NF-κBp65/MAPKs signaling cascade
- (2017) Guangxi Wang et al. Scientific Reports
- Understanding the Physiology of FGF21
- (2016) Ffolliott Martin Fisher et al. Annual Review of Physiology
- Fibroblast growth factor 21 night watch: advances and uncertainties in the field
- (2016) A. Kharitonenkov et al. JOURNAL OF INTERNAL MEDICINE
- Targeting inflammation in metabolic syndrome
- (2016) Francine K. Welty et al. Translational Research
- Insulin resistance by TNF-α is associated with mitochondrial dysfunction in 3T3-L1 adipocytes and is ameliorated by punicic acid, a PPARγ agonist
- (2015) S.S. Anusree et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Oral Angiotensin-(1–7) prevented obesity and hepatic inflammation by inhibition of resistin/TLR4/MAPK/NF-κB in rats fed with high-fat diet
- (2013) Sérgio Henrique Sousa Santos et al. PEPTIDES
- Tejido adiposo: heterogeneidad celular y diversidad funcional
- (2013) Montserrat Esteve Ràfols Endocrinologia y Nutricion
- βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism
- (2012) Xunshan Ding et al. Cell Metabolism
- FGF21 Is Increased by Inflammatory Stimuli and Protects Leptin-Deficientob/obMice from the Toxicity of Sepsis
- (2012) Kenneth R. Feingold et al. ENDOCRINOLOGY
- FGF21 Requires βklotho to Act In Vivo
- (2012) Andrew C. Adams et al. PLoS One
- Inflammatory links between obesity and metabolic disease
- (2011) Carey N. Lumeng et al. JOURNAL OF CLINICAL INVESTIGATION
- Relevant use of Klotho in FGF19 subfamily signaling system in vivo
- (2010) K.-i. Tomiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibroblast Growth Factor 21 Regulates Lipolysis in White Adipose Tissue But Is Not Required for Ketogenesis and Triglyceride Clearance in Liver
- (2009) Yuhei Hotta et al. ENDOCRINOLOGY
- LPS/TLR4 signal transduction pathway
- (2008) Yong-Chen Lu et al. CYTOKINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now